Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $3 | $1 | $1 | $3 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $0 | $0 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 41.9% | 49.3% | 1,535% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 54.2% | 50.2% | 46.5% | -106.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26.7% | -104% | -181.9% | -3,125.4% |
| Net Income | $1 | -$0 | -$0 | -$0 |
| % Margin | 544.5% | -70.4% | -138.6% | -1,929.3% |
| EPS Diluted | 1.2 | -0.11 | -0.145 | -0.124 |
| % Growth | 1,192.9% | 24.3% | -17.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $1 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $1 |